Citas bibligráficas
Prada, M., (2024). Revisión crítica: efecto del consumo de ácidos grasos en la prevención de enfermedades cardiovasculares [Universidad Privada Norbert Wiener]. https://hdl.handle.net/20.500.13053/12464
Prada, M., Revisión crítica: efecto del consumo de ácidos grasos en la prevención de enfermedades cardiovasculares []. PE: Universidad Privada Norbert Wiener; 2024. https://hdl.handle.net/20.500.13053/12464
@misc{renati/1379411,
title = "Revisión crítica: efecto del consumo de ácidos grasos en la prevención de enfermedades cardiovasculares",
author = "Prada Coello, Melissa Consuelo",
publisher = "Universidad Privada Norbert Wiener",
year = "2024"
}
Cardiovascular pathologies are failures of the heart and blood vessels, which can lead to the patient's death due to myocardial infarction. It has been evidenced that ω3 fatty acids reduce the exposure to cardiovascular diseases (coronary heart disease, myocardial infarction) but not to cerebrovascular accidents. The objective of this secondary level research work was to determine the impact of ω-3 supplement intake on the prevention of exposure to cardiovascular diseases (CVD). This was carried out using the Evidence-Based Nutrition (Nube) work strategy. The databases used in the systematic inquiry were: SCOPUS, Pubmed, and Dialnet; 11 studies were found, all of which were selected. The CASPE instrument was used for the judgment of the selection, and the Randomized Clinical Trial titled "Marine ω-3 Supplements and Cardiovascular Diseases: An Updated Meta-Analysis of 13 Randomized Controlled Trials with 127,477 Participants" was chosen, which has a level I rating for both evidence and suggestion category, according to expert competence. It can be concluded from the critical commentary that a dose of 1000 mg/day of marine ω-3 promotes a reduction in the exposure to developing cardiovascular diseases.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons